The Valley Desk

ArticleJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
PubMed ID
43002730
Added to directory
Source checked

Report a correction or request removal